Delivery Order SPE2DB22D2009-SPE2DB25FL9NP
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,197.04 by the Defense Logistics Agency (DLA) on September 29, 2025, with an ultimate completion date of September 30, 2025. The delivery order, issued without set-aside designation, covers the supply of Allegra-D 24 Hour Tablet in quantities of 15 units. This award is issued as a firm fixed-price delivery order under AmerisourceBergen's larger...
- This is a $1,778.91 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Allegra-D 12 Hour Tablet 20S, with a performance period through June 9, 2025. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a $3,437.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ALLEGRA-D 24HR 10S. The place of performance is Conshohocken, Pennsylvania. The delivery order runs from June 23, 2023 to June 28, 2023 to supply allergy medication under the Medical-Surgical Prime Vendor contract. As a major medical distributor, Amerisourcebergen will fulfill this order to support the Defense Logistics Agency's mission of providing...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $862.41 to Amerisourcebergen Drug Corporation for 4561356615 ALLEGRA-D 12 HOUR TABLETs. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 10 boxes of the specified allergy medication to its Conshohocken, Pennsylvania facility on behalf of the Defense Logistics Agency. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the parent company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,180.52 delivery order contract is for the provision of Allegra Allergy 180 mg tablets, which are non-set-aside medical supplies. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary...
- Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp under a firm fixed price contract for $534. The delivery order is for 30 boxes of Allegra-D 12 Hour tablets to be delivered to a location in Conshohocken, Pennsylvania by October 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a pharmaceutical distribution company. No set-aside provision was specified for this delivery order to fulfill the Defense Logistics Agency's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,453.83 firm fixed-price delivery order is for the supply of Allegra allergy 180 mg tablets. The contract has an ultimate completion date of January 23, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Allegra Allergy 180 mg tablets to the Defense Logistics Agency (DLA). The $1,331.70 firm fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a performance period through February 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Allegra Allergy 180 mg tablets, valued at $3,506.48, awarded by the Defense Logistics Agency (DLA) to prime contractor Amerisourcebergen Drug Corp. The contract has a firm fixed price and an ultimate completion date of March 4, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,591.20, is a delivery order contract for Allegra Allergy 180 mg tablets. The contract has an ultimate completion date of January 24, 2025 and utilizes a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FL9NPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,571.84 to AmerisourceBergen Drug Corp for Allegra-D 12 Hour Tablet 30-count units on June 3, 2025, with completion scheduled for June 4, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed price delivery order for pharmaceutical supplies to support federal medical procurement needs. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills a critical role in the federal medical supply chain, providing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet competitive procurement requirements across a wide range of pharmaceutical products and order values. This delivery order exemplifies the operational flexibility of the DLA's pharmaceutical prime vendor program in addressing routine medical supply needs for military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 6/3/25 |